Milestone Pharmaceuticals Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts - HootDex Digital Asset Education & Support Center

Markets ▼
Available Markets
HootDex Exchange & Market Intelligence

Get real-time pricing and trade various tokens on HootDex, access the high fidelity data available for each token, access digital asset liquidity, institutional order logs, and custom asset tokenization metrics built on the Pecu Novus architecture.
Getting Started ▼
User Guides
Infrastructure Layers
Developer Environment
Tokens ▼
Core Assets
Digital Credit Notes & Perpetuals
Yield & DBT Tokens
Specialty Profiles
What is the Fair Market Price : WTFM Evaluation
Support ▼
Support
Announcements
Support Overview

Support is a part of the Education Center and for institutions they will be able to get direct assistance with institutional desk onboarding or liquidity parameters, For the most up to date information please connect safely via mChatHive to stay up to date.
Education ▼
Knowledge Base
HootDex Education Center

Learn more about HootDex, blockchain technology, architectural intricacies governing protocols, digital asset & credit structures, and decentralized order books through detailed whitepapers and documentation.
Architecture ▼
Protocol Specifications
Engine Specifications

HootDex functions on a high-fidelity algorithmic match clearing layer known as a Decentralised Central Limit Order Book, maximizing network transaction bandwidth while ensuring fully non-custodial decentralized security frameworks.
Pecu Wallet ▼
Network Links
Pecu Wallet & Explorer Access

These links will bring you to your Pecu Wallet, Pecuscan and the Github repository for Pecu Novus, so you can Interact safely with the primary open-source transaction ledger.

Earnings report for Milestone Pharmaceuticals Inc. (MIST) expected on March 19. Analysts predict 16 cents per share on $1.20M revenue.

Latest Ratings for MIST

DateFirmActionFromTo Mar 2021HC Wainwright & Co.Initiates Coverage OnBuy Jul 2020OppenheimerUpgradesPerformOutperform Jul 2020JefferiesUpgradesHoldBuy

View More Analyst Ratings for MIST

View the Latest Analyst Ratings

Importance Rank:

Latest Ratings for MIST

You May Also Like

Crypto sentiment shifts off extreme fear, but ‘mixed emotions’ persist

UK bosses hit out at impact of Westminster turmoil on business

Getting Started

Asset Classes

Credit & Composables

Market Access

HootDex Hub